Search
for

    GlossaryBRAVE-AA1

    clinical trial for baricitinib treating alopecia areata

    BRAVE-AA1 is a clinical trial designed to evaluate the efficacy and safety of a medication called baricitinib for treating alopecia areata, an autoimmune condition that causes hair loss. The trial aims to determine how well baricitinib, a Janus kinase (JAK) inhibitor, can help regrow hair in individuals with this condition.

    Related Terms

    Sort by

    Experts

    Clinics